Vellanki Avanish 4
4 · Rain Oncology Inc. · Filed Feb 17, 2023
Insider Transaction Report
Form 4
Vellanki Avanish
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2023-02-15+318,600→ 318,600 totalExercise: $9.30Exp: 2033-02-15→ Common Stock (318,600 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 318,600 shares of the Issuer's common stock, one quarter of which will vest on February 15, 2024, with the remaining three quarters vesting in equal monthly installments through February 15, 2027, subject to the Reporting Person's continued service to the Issuer.